Race a factor in mortality in heart attack patients on anti-clotting drug

The first genetic variations linked to race have been identified that begin to explain a higher risk of death among some African American and Caucasian patients taking the anti-clotting drug clopidogrel after a heart attack. In particular, the team found that two DNA variants common in African Americans were associated with an increased risk of both bleeding and death. In Caucasians, a different variant was linked to additional heart attacks and a higher risk of death.

http://feeds.sciencedaily.com/~r/sciencedaily/~3/isHOwDr3uE8/140618100612.htm

Source: ScienceDaily Headlines - June 18, 2014 Category: Science Source Type: news